Journal
ARCHIVES OF DISEASE IN CHILDHOOD
Volume 97, Issue 8, Pages 698-703Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/archdischild-2011-300771
Keywords
-
Categories
Funding
- University of Balochistan Higher Education Commission of Pakistan
- NHS Research Scotland
- Medical Research Council (MRC) [G0800675]
- Catherine McEwan Foundation
- Yorkhill IBD fund
- MRC [G0600329, G0800759, G0800675] Funding Source: UKRI
- Chief Scientist Office [ETM/137, ETM/100] Funding Source: researchfish
- Medical Research Council [G0600329, G0800675, G0800759] Funding Source: researchfish
Ask authors/readers for more resources
Introduction It is unclear whether recent therapeutic advances have improved the growth of children with Crohn's disease (CD). Aim To assess the frequency of short stature and poor growth and their relationship to disease course and therapy in children with CD. Methods The anthropometric and treatment details of 116 children (68 male) with a mean (range) age at diagnosis of 10.8 years (4.9-15.5) and a mean age at maximum follow-up (MF) of 15.4 years (9.4-19.3) were studied retrospectively at diagnosis (T0), at 1 (T1), 2 (T2) and 3 years (T3) after diagnosis and at MF. Results At T0, mean height SD score (HtSDS) was -0.5 (-3.3 to 2.6) compared to a mid-parental HtSDS of 0.2 (-2.0 to 01.4) (p=0.002). At T1, T2, T3 and MF, mean HtSDS was -0.6 (-4.8 to 7.8), -0.6 (-2.9 to 2.2), -0.7 (-3.6 to 2.5) and -0.5 (-3.5 to 2.9), respectively. Mean Ht velocity (HV) SDS at T1, T2, T3 and MF was -1.4 (-7.4 to 7.4), -0.6 (-7.5 to 6.1), -0.1 (-6.6 to 7.6) and 0.6 (-4.8 to 7.8), respectively (p<0.05). In final models, HtSDS was associated negatively with the use of prednisolone (p=0.0001), azathioprine (p=0.0001), methotrexate (p=0.0001) and weight SDS (WtSDS) (p=0.0001). HVSDS was associated positively with age (p=0.0001) and WtSDS (p=0.01). Delta HtSDS was associated negatively with use of prednisolone (p<0.02). Conclusion Although current therapy for CD is associated with improved rate of growth for the first few years, a substantial proportion of children remain short. This study also highlights the need for consistency in describing growth in children with chronic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available